Related Experiment Video
Updated: Mar 19, 2026
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Functional roles of CSPG4/NG2 in chondrosarcoma
Nuor S M Jamil1, Asim Azfer1, Harrison Worrell1
1Centre for Genomic and Experimental Medicine, MRC IGMM, University of Edinburgh, Edinburgh, UK.
Abstract:
CSPG4/NG2 is a multifunctional transmembrane protein with limited distribution in adult tissues including articular cartilage. The purpose of this study was to investigate the possible roles of CSPG4/NG2 in chondrosarcomas and to establish whether this molecule may have potential for targeted therapy. Stable knock-down of CSPG4/NG2 in the JJ012 chondrosarcoma cell line by shRNA resulted in decreased cell proliferation and migration as well as a decrease in gene expression of the MMP (matrix metalloproteinase) 3 protease and ADAMTS4 (aggrecanase). Chondrosarcoma cells in which CSPG4/NG2 was knocked down were more sensitive to doxorubicin than wild-type cells. The results indicate that CSPG4/NG2 has roles in regulating chondrosarcoma cell function in relation to growth, spread and resistance to chemotherapy and that anti-CSPG4/NG2 therapies may have potential in the treatment of surgically unresectable chondrosarcoma.
Insights
CSPG4/NG2 protein impacts chondrosarcoma growth, spread, and chemotherapy resistance. Targeting CSPG4/NG2 may offer new therapeutic strategies for unresectable chondrosarcoma.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- CSPG4/NG2 is a transmembrane protein found in adult articular cartilage.
- Its role in chondrosarcoma, a bone cancer, is not well understood.
Purpose of the Study:
- Investigate CSPG4/NG2 functions in chondrosarcoma.
- Evaluate CSPG4/NG2 as a potential target for cancer therapy.
Main Methods:
- Utilized shRNA to stably knock down CSPG4/NG2 in JJ012 chondrosarcoma cells.
- Assessed effects on cell proliferation, migration, and gene expression.
- Determined sensitivity to doxorubicin chemotherapy.
Main Results:
- CSPG4/NG2 knockdown reduced chondrosarcoma cell proliferation and migration.
- Decreased expression of MMP3 and ADAMTS4 observed after knockdown.
- CSPG4/NG2-deficient cells showed increased sensitivity to doxorubicin.
Conclusions:
- CSPG4/NG2 plays a role in chondrosarcoma cell growth, invasion, and chemoresistance.
- Targeting CSPG4/NG2 presents a potential therapeutic avenue for chondrosarcoma treatment.
More Related Videos
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
